PGK1-AR axis: Benefits of a novel actor in PCOS pathology
Teresa Vezza, Milagros Rocha, Víctor Manuel Víctor
EBioMedicine · 2020
doi:10.1016/j.ebiom.2020.103110 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder amongst women of reproductive age [1]. The National Institutes of Health (NIH) estimates that cases of PCOS have tripled in the last 25 years, affecting one out of ten women worldwide [2]. Symptoms include menstrual irregularities, hyperandrogenism, disordered folliculogenesis, multiple small subcapsular cystic follicles, chronic anovulation, and infertility [1]. Besides reproductive abnormalities, PCOS is strongly associated with a large series of other disorders, including obesity, insulin resistance, dyslipidaemia, cardiovascular diseases, chronic low-grade inflammation, type 2 diabetes mellitus, hirsutism, alopecia, skin tags, acne, and psychological disturbances [1].
Abstract licence: CC BY-NC
References8
- 1.
- 4.
- 6.
5 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.